Literature DB >> 15660236

A case of idiopathic hypertrophic cranial pachymeningitis manifested only by positive rheumatoid factor and abnormal findings of the anterior falx.

Motoko Kanemoto1, Yasuhiro Ota, Taro Karahashi, Norio Nozue.   

Abstract

In this report, we present a rare case of a 52-year-old man with a unique form of hypertrophic pachymeningitis involving the anterior part of the falx and who was positive for rheumatoid factor. The clinical symptom was only headache, without any cranial nerve palsies or ataxia. Diagnosis was made by gallium scintigraphy and magnet resonance imaging but was not confirmed by dural biopsy. Treatment with corticosteroid alone was extremely effective for him, while in most cases hypertrophic pachymeningitis recurs or progresses despite the treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660236     DOI: 10.1007/s00296-004-0482-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sjögren's syndrome.

Authors:  J Y Li; P H Lai; H C Lam; L Y Lu; H H Cheng; J K Lee; Y K Lo
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

2.  [Intracranial granulomatous pachymeningitis with pseudotumoral symptomatology. Apropos of 4 cases].

Authors:  D Michel; P F Girard; M Tommasi; R Masson; M Trillet; J P Piccinali
Journal:  J Med Lyon       Date:  1969-04-05

3.  Hypertrophic cranial pachymeningitis: assessment with CT and MR imaging.

Authors:  N Martin; C Masson; D Henin; D Mompoint; C Marsault; H Nahum
Journal:  AJNR Am J Neuroradiol       Date:  1989 May-Jun       Impact factor: 3.825

4.  Hypertrophic granulomatous cranial pachymeningitis causing progressive blindness in a chronic dialysis patient.

Authors:  E R Feringa; L Weatherbee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-12       Impact factor: 10.154

5.  [An old man presenting with fluctuating bilateral multiple cranial nerve palsies and positive test for perinuclear antineutrophil cytoplasmic antibody].

Authors:  Y Sugiyama; M Shimizu; A Hoshi; T Aoki; Y Matsuura; S Tochikubo; S Shimizu; A Muroi; M Honma; T Yamamoto
Journal:  No To Shinkei       Date:  1999-09

Review 6.  Idiopathic hypertrophic cranial pachymeningitis. Report of three cases.

Authors:  A N Mamelak; W M Kelly; R L Davis; M L Rosenblum
Journal:  J Neurosurg       Date:  1993-08       Impact factor: 5.115

7.  Gallium imaging of rheumatoid pachymeningitis.

Authors:  W L Higgins; G D Marano
Journal:  Clin Nucl Med       Date:  1986-05       Impact factor: 7.794

Review 8.  Idiopathic chronic hypertrophic craniocervical pachymeningitis: case report.

Authors:  C Botella; M Orozco; J Navarro; P Riesgo
Journal:  Neurosurgery       Date:  1994-12       Impact factor: 4.654

9.  Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis.

Authors:  J R Berger; S Snodgrass; J Glaser; M J Post; M Norenberg; P Benedetto
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910

Review 10.  Inflammatory central nervous system involvement in rheumatoid arthritis.

Authors:  J M Bathon; L W Moreland; A G DiBartolomeo
Journal:  Semin Arthritis Rheum       Date:  1989-05       Impact factor: 5.532

View more
  3 in total

Review 1.  [Hypertrophic cranial pachymeningitis as a rare cause of headache].

Authors:  J Kuhn; A Harzheim; S Riku; W Müller; H Bewermeyer
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

2.  Unusual central nervous system involvement of rheumatoid arthritis: successful treatment with steroid and azathioprine.

Authors:  Asuman Sengoz Inan; Seval Masatlıoglu; Seyfi C Ozyurek; Derya Engin; Ilknur Erdem
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

Review 3.  Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.

Authors:  T Bosman; C Simonin; D Launay; S Caron; A Destée; L Defebvre
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.